Monday, February 16, 2026 2/16/2026

TRPC4-mediated calcium signals accelerate vascular remodeling in pulmonary arterial hypertension

Award Number: K25HL136869
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 07/01/2017
PERIOD OF PERFORMANCE END DATE: 06/30/2023

Group Awards By:

View Award Description

TRPC4-mediated calcium signals accelerate vascular remodeling in pulmonary arterial hypertension - Abstract Pulmonary arterial hypertension (PAH) is an incurable disease of elevated pulmonary artery pressure that culminates in death due to right heart failure. The etiology of PAH is comprised of increased vasoconstriction in resistance arteries and remodeling of the arterial microcirculation. All current therapies for PAH target vasoconstriction, but patient survival has not improved because remodeling remains irreversible. Thus, there has been considerable impetus to determine the mediators of remodeling in PAH. Members of the transient receptor potential (TRP) family ion channels have been implicated as drivers of vascular proliferation and remodeling in PAH. Our lab has shown that TRPC4, a subtype of the canonical TRP family, increases mortality and vascular lesion number and severity in PAH. A separate mechanism of hemodynamic perturbations resulting in turbulent or oscillatory endothelial shear stress has also been associated with increased vascular resistance and remodeling in PAH. Given that both TRPC4 and shear-induced signals are linked by the nexus of intracellular calcium, we hypothesize that TRPC4 and shear-mediated endothelial calcium signals will exacerbate lesion formation in PAH. Therefore, the goal of this proposal is to determine the interaction between TRPC4-dependent endothelial calcium signals and oscillatory shear stress as a driver of occlusive remodeling in PAH. Determining the underlying basis of vascular remodeling in PAH may lead to a novel class of PAH therapeutics for extending patient survival and improving quality of life. As a candidate trained in the quantitative areas of computational modeling and animal physiology at the Center for Lung Biology, I am well suited to investigate the determinants of vascular remodeling in PAH. Furthermore, the goals of this award are aligned with my specific career goals of gaining research expertise, education, and professional skills on my path to career independence. The proposed research plan takes advantage of the robust institutional environment and considerable expertise in the pathophysiology of PAH. The project mentor, Dr. Troy Stevens, and additional personnel are well known experts in the fields of endothelial biology, vascular physiology, and pulmonary hypertension. Additionally, our state-of-the-art laboratories have the requisite equipment to complete this work.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$1,631 )
2024	2021	UNIVERSITY OF SOUTH ALABAMA	307 N UNIVERSITY BLVD	MOBILE	AL	36608	MOBILE	USA	Lung Diseases Research	000	5	1/22/2024	NON-COMPETING CONTINUATION	-$1,631
														Subtotal = -$1,631

Issue Date FY: 2021 ( Subtotal = $159,548 )
2021	2021	UNIVERSITY OF SOUTH ALABAMA	307 UNIVERISTY BLVD 380 ADMINISTRATION BLDG	MOBILE	AL	36688	MOBILE	USA	Lung Diseases Research	000	5	6/10/2021	NON-COMPETING CONTINUATION	$159,548
														Subtotal = $159,548

Issue Date FY: 2020 ( Subtotal = $159,548 )
2020	2020	UNIVERSITY OF SOUTH ALABAMA	307 UNIVERISTY BLVD 380 ADMINISTRATION BLDG	MOBILE	AL	36688	MOBILE	USA	Lung Diseases Research	000	4	6/24/2020	NON-COMPETING CONTINUATION	$159,548
														Subtotal = $159,548

Issue Date FY: 2019 ( Subtotal = $159,548 )
2019	2019	UNIVERSITY OF SOUTH ALABAMA	307 UNIVERISTY BLVD 380 ADMINISTRATION BLDG	MOBILE	AL	36688	MOBILE	USA	Lung Diseases Research	000	3	7/29/2019	NON-COMPETING CONTINUATION	$159,548
														Subtotal = $159,548

Issue Date FY: 2018 ( Subtotal = $159,548 )
2018	2018	UNIVERSITY OF SOUTH ALABAMA	307 UNIVERISTY BLVD 380 ADMINISTRATION BLDG	MOBILE	AL	36688	MOBILE	USA	Lung Diseases Research	000	2	6/21/2018	NON-COMPETING CONTINUATION	$159,548
														Subtotal = $159,548

Issue Date FY: 2017 ( Subtotal = $159,548 )
2017	2017	UNIVERSITY OF SOUTH ALABAMA	380 ADMINISTRATION BUILDING	MOBILE	AL	36688	MOBILE	USA	Lung Diseases Research	000	1	7/1/2017	NEW	$159,548
														Subtotal = $159,548

Grand Total All Awards = $796,109

Top

All Categories

About

Search

Reports

Data Submission

Award Information

TRPC4-mediated calcium signals accelerate vascular remodeling in pulmonary arterial hypertension

Award Number: K25HL136869

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 07/01/2017

PERIOD OF PERFORMANCE END DATE: 06/30/2023

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer